Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Pembrolizumab Market Report 2016

  • QYR789509
  • 99 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Pembrolizumab

Revenue, means the sales value of Pembrolizumab

This report studies sales (consumption) of Pembrolizumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Merck & Co., Inc.

Novartis AG

Onxeo SA

Sumitomo Dainippon Pharma Co., Ltd.

Taiwan Liposome Company, Ltd.

Tiziana Life Sciences Plc

...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Pembrolizumab in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Pembrolizumab Market Report 2016

1 Pembrolizumab Overview

1.1 Product Overview and Scope of Pembrolizumab

1.2 Classification of Pembrolizumab

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Pembrolizumab

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pembrolizumab (2011-2021)

1.4.1 United States Pembrolizumab Sales and Growth Rate (2011-2021)

1.4.2 United States Pembrolizumab Revenue and Growth Rate (2011-2021)

2 United States Pembrolizumab Competition by Manufacturers

2.1 United States Pembrolizumab Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Pembrolizumab Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Pembrolizumab Average Price by Manufactures (2015 and 2016)

2.4 Pembrolizumab Market Competitive Situation and Trends

2.4.1 Pembrolizumab Market Concentration Rate

2.4.2 Pembrolizumab Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Pembrolizumab Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Pembrolizumab Sales and Market Share by Type (2011-2016)

3.2 United States Pembrolizumab Revenue and Market Share by Type (2011-2016)

3.3 United States Pembrolizumab Price by Type (2011-2016)

3.4 United States Pembrolizumab Sales Growth Rate by Type (2011-2016)

4 United States Pembrolizumab Sales (Volume) by Application (2011-2016)

4.1 United States Pembrolizumab Sales and Market Share by Application (2011-2016)

4.2 United States Pembrolizumab Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Pembrolizumab Manufacturers Profiles/Analysis

5.1 Merck & Co., Inc.

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Pembrolizumab Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Merck & Co., Inc. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Novartis AG

5.2.2 Pembrolizumab Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Novartis AG Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Onxeo SA

5.3.2 Pembrolizumab Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Onxeo SA Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Sumitomo Dainippon Pharma Co., Ltd.

5.4.2 Pembrolizumab Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Taiwan Liposome Company, Ltd.

5.5.2 Pembrolizumab Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Taiwan Liposome Company, Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Tiziana Life Sciences Plc

5.6.2 Pembrolizumab Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Tiziana Life Sciences Plc Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

...

6 Pembrolizumab Manufacturing Cost Analysis

6.1 Pembrolizumab Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Pembrolizumab

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Pembrolizumab Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Pembrolizumab Market Forecast (2016-2021)

10.1 United States Pembrolizumab Sales, Revenue Forecast (2016-2021)

10.2 United States Pembrolizumab Sales Forecast by Type (2016-2021)

10.3 United States Pembrolizumab Sales Forecast by Application (2016-2021)

10.4 Pembrolizumab Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Pembrolizumab

Table Classification of Pembrolizumab

Figure United States Sales Market Share of Pembrolizumab by Type in 2015

Table Application of Pembrolizumab

Figure United States Sales Market Share of Pembrolizumab by Application in 2015

Figure United States Pembrolizumab Sales and Growth Rate (2011-2021)

Figure United States Pembrolizumab Revenue and Growth Rate (2011-2021)

Table United States Pembrolizumab Sales of Key Manufacturers (2015 and 2016)

Table United States Pembrolizumab Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Pembrolizumab Sales Share by Manufacturers

Figure 2016 Pembrolizumab Sales Share by Manufacturers

Table United States Pembrolizumab Revenue by Manufacturers (2015 and 2016)

Table United States Pembrolizumab Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Pembrolizumab Revenue Share by Manufacturers

Table 2016 United States Pembrolizumab Revenue Share by Manufacturers

Table United States Market Pembrolizumab Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Pembrolizumab Average Price of Key Manufacturers in 2015

Figure Pembrolizumab Market Share of Top 3 Manufacturers

Figure Pembrolizumab Market Share of Top 5 Manufacturers

Table United States Pembrolizumab Sales by Type (2011-2016)

Table United States Pembrolizumab Sales Share by Type (2011-2016)

Figure United States Pembrolizumab Sales Market Share by Type in 2015

Table United States Pembrolizumab Revenue and Market Share by Type (2011-2016)

Table United States Pembrolizumab Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Pembrolizumab by Type (2011-2016)

Table United States Pembrolizumab Price by Type (2011-2016)

Figure United States Pembrolizumab Sales Growth Rate by Type (2011-2016)

Table United States Pembrolizumab Sales by Application (2011-2016)

Table United States Pembrolizumab Sales Market Share by Application (2011-2016)

Figure United States Pembrolizumab Sales Market Share by Application in 2015

Table United States Pembrolizumab Sales Growth Rate by Application (2011-2016)

Figure United States Pembrolizumab Sales Growth Rate by Application (2011-2016)

Table Merck & Co., Inc. Basic Information List

Table Merck & Co., Inc. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Merck & Co., Inc. Pembrolizumab Sales Market Share (2011-2016)

Table Novartis AG Basic Information List

Table Novartis AG Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis AG Pembrolizumab Sales Market Share (2011-2016)

Table Onxeo SA Basic Information List

Table Onxeo SA Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Onxeo SA Pembrolizumab Sales Market Share (2011-2016)

Table Sumitomo Dainippon Pharma Co., Ltd. Basic Information List

Table Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales Market Share (2011-2016)

Table Taiwan Liposome Company, Ltd. Basic Information List

Table Taiwan Liposome Company, Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Taiwan Liposome Company, Ltd. Pembrolizumab Sales Market Share (2011-2016)

Table Tiziana Life Sciences Plc Basic Information List

Table Tiziana Life Sciences Plc Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tiziana Life Sciences Plc Pembrolizumab Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Pembrolizumab

Figure Manufacturing Process Analysis of Pembrolizumab

Figure Pembrolizumab Industrial Chain Analysis

Table Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015

Table Major Buyers of Pembrolizumab

Table Distributors/Traders List

Figure United States Pembrolizumab Production and Growth Rate Forecast (2016-2021)

Figure United States Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)

Table United States Pembrolizumab Production Forecast by Type (2016-2021)

Table United States Pembrolizumab Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370